Health
Researchers develop promising new drug candidates to treat ALS – Drug Target Review
Scientists have shown that a Selenium-based drug-molecule called ebselen and other novel compounds can delay ALS onset in mouse models.
Posted: 2 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
Scientists have shown that a Selenium-based drug-molecule called ebselen and other novel compounds can delay ALS onset in mouse models.
Scientists report that they have taken a significant step forward in the search to find effective new drugs for the treatment of Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease.
Researchers from the University of Liverpool, UK, and University of Nagoya, Ja…
-
Noosa News21 hours agoDriver arrested after life-threatening hit-and-run on outskirts of Ipswich, Queensland
-
Business23 hours agoThis ASX 200 mining stock is eyeing the lithium throne
-
Noosa News23 hours ago150 jobs in doubt as Bega winds down peanut processing plants in Queensland
-
Noosa News7 hours agoFormer Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban